Search

Acne is a chronic inflammatory skin disorder that profoundly impacts the quality of life of patients worldwide. While it is predominantly observed in adolescents, it can affect individuals across all age groups. Acne pathogenesis is believed to be a result of various endogenous and exogenous factors, but the precise mechanisms remain elusive. Recent studies suggest that dysbiosis of the skin microbiota significantly contributes to acne development. Specifically, Cutibacterium acnes, the dominant resident bacterial species implicated in acne, plays a critical role in disease progression. Various treatments, including topical benzoyl peroxide, systemic antibiotics, and photodynamic therapy, have demonstrated beneficial effects on the skin microbiota composition in acne patients. Of particular interest is the therapeutic potential of probiotics in acne, given its direct influence on the skin microbiota. This review summarizes the alterations in skin microbiota associated with acne, provides insight into its pathogenic role in acne, and emphasizes the potential of therapeutic interventions aimed at restoring microbial homeostasis for acne management. [ABSTRACT FROM AUTHOR]

Semiconducting polymers are attractive optical materials in optoelectronic devices and biomedical applications because of their superior optical properties and remarkable versatility. Optical imaging in the second near‐infrared window (NIR‐II) has become increasingly popular owing to the merits of large penetration depth and high signal to noise ratio, leading to a great deal of interest in the exploration and development of optical probes in the NIR‐II region. In this review, recent advances in the development of semiconducting polymer nanoparticles (SPNs) in the NIR‐II region for biomedical imaging and therapeutics are summarized. This review focuses on the design strategies in semiconducting polymers toward enhancing their NIR‐II emission for deep tissue imaging, improving their performance in photoacoustic imaging, utilizing their large absorptivity for photothermal and photodynamic therapy, and a number of comprehensive applications for multifunctional imaging and optical therapeutics. Finally, the current challenges of semiconducting polymer probes are discussed and the perspectives on the future development in the field are shared. [ABSTRACT FROM AUTHOR]

Polyamine detection and depletion have been extensively investigated for cancer prevention and treatment. However, the therapeutic efficacy is far from satisfactory, mainly due to a polyamine compensation mechanism from the systemic circulation in the tumor environment. Herein, we explore a new solution for improving polyamine detection as well as a possible consumption therapy based on a new photosensitizer that can efficiently consume polyamines via an irreversible chemical reaction. The new photosensitizer is pyrrolopyrroleaza-BODIPY pyridinium salt (PPAB-PyS) nanoparticles that can react with the over-expressed polyamine in cancer cells and produce two photosensitizers with enhanced phototoxicity on cancer destruction. Meanwhile, PPAB-PyS nanoparticles provide a simultaneous ratiometric fluorescence imaging of intracellular polyamine. This combination polyamine consumption with a chemical reaction provides a new modality to enable polyamine detection along with photodynamic therapy as well as a putative depletion of polyamines for cancer treatment and prevention. Li et al develop PPAB-PyS nanoparticles that simultaneously allows intracellular imaging and ratiometric detection of the intracellular polyamine. With an additional potential to consume polyamines via an irreversible chemical reaction, the authors thus provide an alternative approach for photodynamic therapy with polyamine detection. [ABSTRACT FROM AUTHOR]

In photodynamic therapy (PDT), selection of an ideal photosensitizer and improvement of its photodynamic activities are currently of great interest. In this work, a chlorophyll-a photosensitizer derivative, p-bromo-phenylhydrazone-methyl pyropheophorbide-a (BPMppa) with a long absorption wavelength (683 nm) and a large molar extinction coefficient (7.03 × 104 M−1 cm−1), which is considered to be more suitable for the treatment of deep cancer, is loaded onto pristine graphene using a direct graphite exfoliation process viaπ–π stacking in water. The obtained graphene loaded photosensitizer G–BPMppa composite shows significantly improved water-solubility and dispersity in water, PBS and culture medium, and an increased singlet oxygen (1O2) quantum yield (ΦΔ = 60.55%) in DMF solution compared to free BPMppa (ΦΔ = 29.2%). In addition, cell experiments indicated that the G–BPMppa composite could be taken up by HeLa cells successfully, showing enhanced intracellular uptake behavior. Owing to its enhanced intracellular uptake and higher 1O2 quantum yield, G–BPMppa showed remarkably improved PDT efficiency (IC50: 1.36 ± 0.35 μg mL−1 of equivalent BPMppa) over free BPMppa after irradiation, but low dark toxicity without irradiation. Moreover, cell morphological changes after G–BPMppa PDT further qualitatively demonstrated that G–BPMppa could induce damage and apoptotic cell death efficiently. Furthermore, the photochemical mechanism of the G–BPMppa mediated PDT process was investigated by using specific quenching agents, sodium azide (SA, a singlet oxygen quencher) and d-mannitol (DM, a hydroxyl radical quencher); the results indicated that type I and type II photodynamic reactions could occur simultaneously, yet the type II reaction (the generation of 1O2) might play a predominant role in the G–BPMppa induced PDT process. [ABSTRACT FROM AUTHOR]

Photodynamic therapy (PDT) is entering the mainstream of the cancer treatments recently. Pyropheophorbide-a (Pa), as a degradation product of chlorophyll-a, has been shown to be a potent photosensitizer in photodynamic therapy. In this paper, we investigated the in vitro photodynamic therapy of 13 1 - ortho -trifluoromethyl-phenylhydrazone modified pyropheophorbide-a (PHPa) against human HeLa cervical cancer cell line, together with ultraviolet-visible spectra, fluorescence emission spectra, stability in various solvents, and single oxygen quantum yield. The results indicated that PHPa not only showed a greater molar extinction coefficient reached 4.55 × 10 4  L mol −1 cm −1 , the long absorption wavelength (681 nm) as we expected that makes it potential in deep tumor treatment, but also showed better stability in near neutral phosphate buffers (pH 7.4) and culture medium, as well as higher single oxygen quantum yield (Ф D = 40.5%) in DMF solutions. Moreover, cell experiments suggested that PHPa could be uptaken by HeLa cells successfully, and has low dark toxicity without irradiation, but remarkable photo-cytotoxicity (IC 50 , 1.92 ± 0.59 μ M) that the inhibition rate of HeLa cells could increase up 91.4% at 30 μM of PHPa after irradiation. In addition, morphological changes of HeLa cells further demonstrated that PHPa can induce damage and apoptotic cell death. Furthermore, the mechanism of photochemical processes was investigated by using specific quenching agent sodium azide (SA) and D-mannitol (DM), respectively, which showed the formation of singlet oxygen (Type II reaction mechanism) may play a predominant role, Type I and Type II photodynamic reactions could occur simultaneously in this PHPa mediated PDT process. [ABSTRACT FROM AUTHOR]

Magnetic iron oxide modified pyropheophorbide-a fluorescence nanoparticles, Fe3O4@SiO2@APTES@PPa (FSAP), were designed as magnetically targeted photodynamic antineoplastic agents and prepared through continuous covalent chemical modification on the surface of Fe3O4 nanoparticles. The properties of the intermediates and the final product were comprehensively characterized by transmission electron microscopy, powder X-ray diffraction analysis, Fourier transform infrared spectroscopy, vibrating sample magnetometry, zeta potential measurement, ultraviolet-visible absorption spectroscopy, fluorescence emission spectroscopy, and thermogravimetric analysis. In this work, we demonstrated the in vitro photodynamic therapy (PDT) of FSAP against ovarian cancer (SKOV-3) cells, which indicated that FSAP could be taken up successfully and showed low dark toxicity without irradiation, but remarkable phototoxicity after irradiation. Meanwhile, FSAP had showed good biocompatibility and low dark toxicity against normal cells in the biological experiments on mouse normal fibroblast cell lines (L929 cells). In addition, in the photochemical process of FSAP mediated photodynamic therapy, the Type-II photo-oxygenation process (generated singlet oxygen) played an important role in the induction of cell damage. [ABSTRACT FROM AUTHOR]

Patients suffering from cancer have benefited from combination therapy. Nanocarriers are the ideal candidates for combination therapy. In this study, we constructed docetaxel (DTX) loaded micellar nanomedicines co-loaded with near infrared (NIR) dye-IR820 for photothermal therapy (PTT)/photodynamic therapy (PDT)/chemotherapy of breast cancer. Lyp-1, a tumor homing peptide, was introduced into the nanosystems to construct the active targeting nanomedicine. In order to deliver IR820 to the tumor site and overcome its short lifetime in vivo , a PEI derivative—PCL-g-PEI was introduced. IR820 with negative charge was formed stable static interaction with the amine groups, meanwhile, the absorption of IR820 in the NIR region was weakened. It indicated that the nanosystem constructed in this study may provide an alternative candidate for mild PTT. By the evaluation of the photothermal conversion in vivo , we can confirm that IR820 has been successfully delivered and effectively accumulated in the tumor site. Furthermore, the tumor cells targeting and anticancer performances of this nanosystem have been studied in vitro and in vivo . The results demonstrated Lyp-1 modification has enhanced the tumor targeting delivery of DTX and IR820. By combining PTT and PDT, DTX nanomedicine efficiently inhibited the growth and metastasis of breast cancer in mice. This nanosystem is a promising candidate for combination therapy of breast cancer. [ABSTRACT FROM AUTHOR]

Novel chlorin photosensitizer pyropheophorbide-a (PPA) coated multifunctional magneto-fluorescent nanoparticles Fe3O4@SiO2@CS@PPA (MFCSPPA) about 50 nm in diameter were strategically designed and prepared for photodynamic therapy (PDT) based on the good solubility and magnetic targeting of Fe3O4@SiO2 nanoparticles, excellent biocompatibility and biodegradability of chitosan (CS) polymer, and the unique fluorescence and photodynamic activity of pyropheophorbide-a. In this work, we found that magneto-fluorescent MFCSPPA has high saturation magnetization of 23.7 emu g−1, and showed super-paramagnetic properties, good dispersion in alcohol and water, excellent water-solubility, improved biocompatibility and good photoluminescence properties. In addition, we demonstrated MFCSPPA mediated singlet oxygen production in solution conditions by using 1,3-diphenylisobenzofuran (DPBF) as a fluorescence detector. Moreover, the in vitro PDT activities against human HeLa cervical cancer cells were investigated by MTT assay. The phototoxicity experiments showed that MFCSPPA has strong photodynamic therapy activity and low dark toxicity, and the cancer cell viability was reduced to 18% after treatment with PDT. Phagocytosis of MFCSPPA experiments indicated that it could be successfully taken up to some extent by HeLa cells with a suitable lipo-hydro partition coefficient and biocompatibility. Acridine orange/ethidium bromide (AO/EB) double fluorescence staining suggested that the cells are all in a state of apoptosis or necrosis after PDT treatment for 6 h. In addition, we studied the formation of reactive oxygen species in HeLa cells after MFCSPPA-PDT treatment; the results suggested that type I and type II photodynamic reactions can occur simultaneously, yet type I photodynamic reactions have a slight edge over type II. The as-prepared magneto-fluorescent MFCSPPA nanoparticles are suitable for simultaneous PDT and medical fluorescence imaging. [ABSTRACT FROM AUTHOR]

• Chemical modified BPQDs possess the same negative charge as the surface of the cells and achieve stability in the body. • In the tumor microenvironment, the positive charge and tumor-targeted polypeptides are exposed through the charge flip, so that BPQDs can enter tumor cells efficiently and increase their photodynamic effectiveness. Black phosphorus quantum dots(BPQDs) have shown a good application prospect in the field of tumor therapy due to their photoelectric effect and good biodegradability. Due to the active endocytosis and fast metabolic efficiency of tumor cells, BPQDs are easy to be absorbed by tumor cells. However, this does not guarantee that BPQDs will be completely targeted to tumor cells, and normal cells will also absorb BPQDs. Because the cell membrane is negatively charged, BPQDs are also negatively charged and are not easily absorbed by cells under the action of electrostatic repulsion. Surface pegylation is the most common modification method of black phosphorus at present. However, surface pegylation can reduce the uptake of BPQDs by tumor cells. Positive PEG is also easy to be recognized and swallowed by the reticuloendothelial system. The inherent instability and poor tumor targeting of BPQDs under physiological conditions limit further research and clinical application. For this purpose, we selected cationic polymer polyethylenimine (PEI) to modify BPQDs and then added RGD peptides targeting tumor cells. An outer layer of negatively charged PEG+DMMA makes the nanosystem more stable. In the acidic environment of the tumor, the PEG layer has a charge reversal, and the positively charged PEI and the RGD polypeptide BPQDs targeted by the tumor cells are released into the tumor cells. It provides a new method for efficiently and accurately transporting BPQDs, a novel photosensitive nanomaterial, into tumor cells for photodynamic therapy. [ABSTRACT FROM AUTHOR]